2022 annual financial data
Akari Therapeutics 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -23,088,000 USD and net income was -17,748,000 USD.
Operating cash flow was -21,504,000 USD.
Get free Akari Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -23,088,000 USD
- Net income
- -17,748,000 USD
- Operating cash flow
- -21,504,000 USD